| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
Departments of Pharmacology and Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
Rac1, a Rho family GTPase, is a mediator of diverse cellular functions including membrane ruffling, cell cycle progression, and transformation. Rac3, a close relative of Rac1, is less well characterized. Posttranslational addition of geranylgeranyl isoprenoid lipids to Rac proteins is required for biological activity. Inhibitors of geranylgeranyl transferase I (GGTIs) are currently under investigation as a possible anticancer therapy, although the targets of GGTIs have not been determined. We created COOH-terminal mutants of Rac1 and Rac3 that are farnesylated and used them to characterize Rac1 and Rac3 as physiological targets of GGTIs. We show that, like Rac1, activated Rac3 causes transformation and leads to membrane ruffling. Farnesylated versions of Rac1 and Rac3 retain the ability to signal to the transcription factor c-Jun and cause membrane ruffling and transformation, indicating that switching isoprenoid modification does not alter function. Finally, treatment with GGTIs led to the inhibition of membrane-ruffling and transforming activities of both activated and wild-type Rac1 and Rac3. However, the farnesylated versions of both activated and wild-type Rac1 and Rac3 were resistant to the inhibitory effects of GGTIs. These results illustrate that Rac1 and Rac3 are potential physiological targets for these novel drugs.
This article has been cited by other articles:
|
|
 |
|
  C. Espina, M. V. Cespedes, M. A. Garcia-Cabezas, M. T. G. del Pulgar, A. Boluda, L. G. Oroz, P. Cejas, M. Nistal, R. Mangues, and J. C. Lacal A Critical Role for Rac1 in Tumor Progression of Human Colorectal Adenocarcinoma Cells Am. J. Pathol., January 1, 2008; 172(1): 156 - 166. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Shutes, C. Onesto, V. Picard, B. Leblond, F. Schweighoffer, and C. J. Der Specificity and Mechanism of Action of EHT 1864, a Novel Small Molecule Inhibitor of Rac Family Small GTPases J. Biol. Chem., December 7, 2007; 282(49): 35666 - 35678. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Falsetti, D.-a. Wang, H. Peng, D. Carrico, A. D. Cox, C. J. Der, A. D. Hamilton, and S. M. Sebti Geranylgeranyltransferase I Inhibitors Target RalB To Inhibit Anchorage-Dependent Growth and Induce Apoptosis and RalA To Inhibit Anchorage-Independent Growth Mol. Cell. Biol., November 15, 2007; 27(22): 8003 - 8014. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Engers, S Ziegler, M Mueller, A Walter, R Willers, and H E Gabbert Prognostic relevance of increased Rac GTPase expression in prostate carcinomas Endocr. Relat. Cancer, June 1, 2007; 14(2): 245 - 256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hajdo-Milasinovic, S. I. J. Ellenbroek, S. van Es, B. van der Vaart, and J. G. Collard Rac1 and Rac3 have opposing functions in cell adhesion and differentiation of neuronal cells J. Cell Sci., February 15, 2007; 120(4): 555 - 566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kimura, K. Kawamoto, S. Teranishi, and T. Nishida Role of rac1 in fibronectin-induced adhesion and motility of human corneal epithelial cells. Invest. Ophthalmol. Vis. Sci., October 1, 2006; 47(10): 4323 - 4329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Chenette, N. Y. Mitin, and C. J. Der Multiple Sequence Elements Facilitate Chp Rho GTPase Subcellular Location, Membrane Association, and Transforming Activity Mol. Biol. Cell, July 1, 2006; 17(7): 3108 - 3121. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Fiordalisi, P. J. Keller, and A. D. Cox PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility. Cancer Res., March 15, 2006; 66(6): 3153 - 3161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Keller, C. M. Gable, M. R. Wing, and A. D. Cox Rac3-Mediated Transformation Requires Multiple Effector Pathways Cancer Res., November 1, 2005; 65(21): 9883 - 9890. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Raney, L. S. Kuo, L. L. Baugh, J. L. Foster, and J. V. Garcia Reconstitution and Molecular Analysis of an Active Human Immunodeficiency Virus Type 1 Nef/p21-Activated Kinase 2 Complex J. Virol., October 15, 2005; 79(20): 12732 - 12741. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Berzat, J. E. Buss, E. J. Chenette, C. A. Weinbaum, A. Shutes, C. J. Der, A. Minden, and A. D. Cox Transforming Activity of the Rho Family GTPase, Wrch-1, a Wnt-regulated Cdc42 Homolog, Is Dependent on a Novel Carboxyl-terminal Palmitoylation Motif J. Biol. Chem., September 23, 2005; 280(38): 33055 - 33065. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. J. Cho, B. Zhang, V. Kaartinen, L. Haataja, I. de Curtis, J. Groffen, and N. Heisterkamp Generation of rac3 Null Mutant Mice: Role of Rac3 in Bcr/Abl-Caused Lymphoblastic Leukemia Mol. Cell. Biol., July 1, 2005; 25(13): 5777 - 5785. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Wennerberg and C. J. Der Rho-family GTPases: it's not only Rac and Rho (and I like it) J. Cell Sci., March 15, 2004; 117(8): 1301 - 1312. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |
